Literature DB >> 18199163

Histopathology of bone marrow reconstitution after umbilical cord blood transplantation for hematological diseases.

Takashi Maeda1, Eisuke Shiozawa, Homma Mayumi, Takako Usui, Hidetoshi Nakashima, Norimichi Hattori, Daisuke Adachi, Bungo Saito, Kouji Yanagisawa, Isao Matsuda, Tsuyoshi Nakamaki, Shigeru Tomoyasu, Toshiko Yamochi-Onizuka, Masafumi Takimoto, Hidekazu Ota.   

Abstract

To study hematopoietic reconstitution in umbilical cord blood transplantation (CBT), bone marrow (BM) histology was investigated in 35 biopsies after bone marrow transplantation (BMT) and in 40 biopsies after CBT. BM biopsies were obtained at different times after transplantation and were evaluated for cellularity, number of megakaryocytes and CD34-positive cells, and fibrosis. In biopsies up to 29 days after BMT, cellularity was increased and megakaryocytes were observed, but at 29 days after CBT, biopsies showed severe cellular depletion and almost no megakaryocytes. In addition, fewer CD34-positive cells were observed after CBT compared to after BMT. After day 30 after CBT, hematopoietic recovery of the BM was gradually observed and after day 100 after transplantation, no essential differences were observed between BMT and CBT. Hematopoietic recovery of the BM after CBT was delayed compared to that after BMT, but engraftment of donor cells after CBT was also observed in histopathologically. To the best of the authors' knowledge this is the first histopathological description of BM reconstitution after CBT.

Entities:  

Mesh:

Year:  2008        PMID: 18199163     DOI: 10.1111/j.1440-1827.2007.02200.x

Source DB:  PubMed          Journal:  Pathol Int        ISSN: 1320-5463            Impact factor:   2.534


  1 in total

1.  Importance of day 21 BM chimerism in sustained neutrophil engraftment following double-unit cord blood transplantation.

Authors:  S Avery; M H Voss; A M Gonzales; M Lubin; H Castro-Malaspina; S Giralt; N A Kernan; A Scaradavou; C V Hedvat; C E Stevens; J N Barker
Journal:  Bone Marrow Transplant       Date:  2011-12-05       Impact factor: 5.483

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.